Menu
FDA · Drug recall

Thyroid…

Jan. 28, 2026 Class II

Date
Jan. 28, 2026
Risk class
Class II (FDA's definition, 21 CFR 7.3(m): a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote)
Status
Ongoing
Filed by
Specialty Process Labs LLC
Product
Thyroid, USP, Rx only, Net Wt: 0.50kg, For Manufacturing, Processing or Repackaging Use Only, Specialty Process Labs, Phoenix, AZ 85034, NDC 81305-100-02
Reason
Subpotent Drug
Distribution pattern
U.S. Nationwide
Quantity
58 gms
Codes and lots
Lot #H22254-1XV; Exp. 01/31/2027
Recall started
Jan. 16, 2026
Recall number
D-0294-2026

What should I do? Medicine recall: what to do

Source: FDA · Drug enforcement report, recall number D-0294-2026. The agency record governs; check it and the company before acting.

Report a mistake on this page